Handelsbanken Fonder AB - DICERNA PHARMACEUTICALS INC ownership

DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 178 filers reported holding DICERNA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.

Quarter-by-quarter ownership
Handelsbanken Fonder AB ownership history of DICERNA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$363,000
-19.0%
18,000
+50.0%
0.00%0.0%
Q2 2021$448,000
+55.0%
12,000
+6.2%
0.00%0.0%
Q1 2021$289,000
+16.1%
11,3000.0%0.00%0.0%
Q4 2020$249,000
+22.7%
11,3000.0%0.00%
+100.0%
Q3 2020$203,000
-64.6%
11,300
-50.0%
0.00%
-50.0%
Q2 2020$574,00022,6000.00%
Other shareholders
DICERNA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,705,392$43,607,0007.88%
Bain Capital Life Sciences Investors, LLC 3,080,237$78,762,0004.46%
DAFNA Capital Management LLC 587,756$15,029,0003.57%
RTW INVESTMENTS, LP 7,463,291$190,836,0002.98%
SILVERARC CAPITAL MANAGEMENT, LLC 200,000$5,114,0002.79%
Evolutionary Tree Capital Management, LLC 122,473$3,132,0001.85%
Parkman Healthcare Partners LLC 303,268$7,755,0001.80%
Eagle Health Investments LP 161,125$4,120,0001.62%
BRIDGER MANAGEMENT, LLC 588,910$15,058,0001.41%
Woodline Partners LP 1,777,000$45,438,0001.01%
View complete list of DICERNA PHARMACEUTICALS INC shareholders